Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 16:14:1358101.
doi: 10.3389/fonc.2024.1358101. eCollection 2024.

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

Affiliations

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

Wen Zhong et al. Front Oncol. .

Abstract

Background: Lung cancer, characterized by its high morbidity and lethality, necessitates thorough research to enhance our understanding of its pathogenesis and discover novel therapeutic approaches. Recent studies increasingly demonstrate that lung cancer cells can modulate the tumor microenvironment, promoting tumor growth, and metastasis through the release of exosomes. Exosomes are small vesicles secreted by cells and contain a variety of bioactive molecules such as proteins, nucleic acids, and metabolites. This paper presents a comprehensive review of exosome research in lung cancer and its progress through bibliometric analysis.

Methods: Publications related to exosomes in lung cancer patients were systematically searched on the Web of Science Core Collection (WoSCC) database. Bibliometric analysis was performed using VOSviwers, CiteSpace, and the R package "Bibliometrics". Publications were quantitatively analyzed using Microsoft Office Excel 2019. The language of publication was restricted to "English" and the search strategy employed TS=(exosomes or exosomes or exosomes) and TS=(lung cancer). The search period commenced on January 1, 2004, and concluded on November 12, 2023, at noon. The selected literature types included Articles and Reviews.

Results: The study encompassed 1699 papers from 521 journals across 71 countries and 2105 institutions. Analysis revealed a consistent upward trend in lung cancer exosome research over the years, with a notable surge in recent times. This surge indicates a growing interest and depth of inquiry into lung cancer exosomes. Major research institutions in China and the United States, including Nanjing Medical University, Shanghai Jiao Tong University, Chinese Academy Of Sciences, and Utmd Anderson Cancer Center, emerged as crucial research hubs. The annual publication count in this field witnessed a continuous rise, particularly in recent years. Key terms such as lung cancer, non-small cell lung cancer (NSCLC), microvesicles, intercellular communication, exosomal miRNAs, and oncology dominated the research landscape. Fields like cell biology, biochemistry, biotechnology, and oncology exhibited close relation with this research. Clotilde Théry emerged as the most cited author in the field, underlining her significant contributions. These results demonstrate the broad impact of exosome research in lung cancer, with key terms covering not only disease-specific aspects such as lung cancer and NSCLC but also basic biological concepts like microvesicles and intercellular communication. Explorations into exosomal microRNAs and oncology have opened new avenues for lung cancer exosome research. In summary, lung cancer exosome research is poised to continue receiving attention, potentially leading to breakthroughs in treatment and prevention.

Conclusion: Publications on lung cancer exosomes show a rising trend year by year, with China and the United States ranking first and second in terms of the number of publications. However, there is insufficient academic learning cooperation and exchanges between the two sides, and Chinese universities account for a large proportion of research institutions in this field. Jing Li is the most productive author, Clotilde Théry is the most co-cited author, and Cancers is the journal with the highest number of publications. The current focus in the field of lung cancer exosomes is on biomarkers, liquid biopsies, immunotherapy, and tumor microenvironment.

Keywords: CiteSpace; bibliometrics; exosomes; knowledge map; lung cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Publications screening flowchart.
Figure 2
Figure 2
Annual output distribution of exosome papers related to lung cancer.
Figure 3
Figure 3
Visual knowledge map of high-yield countries for lung cancer exosome research.
Figure 4
Figure 4
The geographical distribution of high-yield countries for lung cancer exosome research.
Figure 5
Figure 5
Cooperation map of high-yield institutions.
Figure 6
Figure 6
The visualization of authors (A) and co-cited authors (B) on research of exosomes in lung cancer.
Figure 7
Figure 7
The visualization of journals (A) and co-cited journals (B) research of exosomes in lung cancer.
Figure 8
Figure 8
The dual-map overlay of journals on research of exosomes in lung cancer.
Figure 9
Figure 9
The visualization of co-cited references on research of exosomes in lung cancer.
Figure 10
Figure 10
Keyword cluster analysis (A) and Trend topic analysis (B).
Figure 11
Figure 11
Top 10 Keywords with strong citation bursts. A red bar indicates high citations in that year.
Figure 12
Figure 12
Top 15 references with strong citation bursts. A red bar indicates high citations in that year.

Similar articles

Cited by

References

    1. Bade B, Dela Cruz C. Lung cancer 2020: epidemiology, etiology, and prevention. Clinics chest Med. (2020) 41:1–24. doi: 10.1016/j.ccm.2019.10.001 - DOI - PubMed
    1. de Goede O, Nachun D, Ferraro N, Gloudemans M, Rao A, Smail C, et al. . Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease. Cell. (2021) 184:2633–48.e19. doi: 10.1016/j.cell.2021.03.05010.1136/jitc-2019-000376 - DOI - PMC - PubMed
    1. Siegel R, Miller K, Wagle N, Jemal A. Cancer statistics, 2023. CA: Cancer J Clin. (2023) 73:17–48. doi: 10.3322/caac.21763 - DOI - PubMed
    1. Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr., Wu YL, et al. . Lung cancer: current therapies and new targeted treatments. Lancet. (2017) 389:299–311. doi: 10.1016/S0140-6736(16)30958-8 - DOI - PubMed
    1. Li M, Liu L, Dong M. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol cancer. (2021) 20:22. doi: 10.1186/s12943-021-01312-y - DOI - PMC - PubMed

Publication types

LinkOut - more resources